TY - JOUR
T1 - Biological treatment of obstructive lung diseases
AU - Søndergaard, Marianne Baastrup
AU - Madsen, Frederik Roager
AU - Sverrild, Asger
AU - Porsbjerg, Celeste
N1 - Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.
PY - 2024/4/1
Y1 - 2024/4/1
N2 - In the last 30 years, the treatment of obstructive lung diseases, such as asthma and COPD, has seen significant advancements. Introduction of inhaled corticosteroids (ICS) and, more recently, biological treatments has revolutionized care. Biological treatments are very successful in severe asthma and are expected to be approved for COPD soon. Systematic assessment and multidimensional treatment approaches are crucial in both conditions. Future care may involve specialized centres for severe obstructive lung diseases, focusing on personalized approaches and monitoring, as argued in this review.
AB - In the last 30 years, the treatment of obstructive lung diseases, such as asthma and COPD, has seen significant advancements. Introduction of inhaled corticosteroids (ICS) and, more recently, biological treatments has revolutionized care. Biological treatments are very successful in severe asthma and are expected to be approved for COPD soon. Systematic assessment and multidimensional treatment approaches are crucial in both conditions. Future care may involve specialized centres for severe obstructive lung diseases, focusing on personalized approaches and monitoring, as argued in this review.
KW - Humans
KW - Pulmonary Disease, Chronic Obstructive/drug therapy
KW - Administration, Inhalation
KW - Asthma/drug therapy
KW - Adrenal Cortex Hormones/therapeutic use
UR - http://www.scopus.com/inward/record.url?scp=85190491273&partnerID=8YFLogxK
U2 - 10.61409/V10230671
DO - 10.61409/V10230671
M3 - Review
C2 - 38606702
SN - 0041-5782
VL - 186
JO - Ugeskrift for Laeger
JF - Ugeskrift for Laeger
IS - 14
ER -